PALI Palisade Bio, Inc.
$1.20▼ -2.44%
Healthcare
Other
After hours
$1.20▲ +0.00%
Oct 27, 4:45 PM ET
Volume 6.01M
Avg Volume (10D) 2.17M
Key Metrics & Fundamentals
Market Cap
$209.12M
P/E Ratio
2.0
Div Yield
0.00%
52W Range
1.17 - 2.86
% vs 50 MA
-29.78%
% vs 200 MA
-35.55%
RSI-14
31.9
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.26
Free Cash Flow
-$7.60M
Gross Rev
$500,000
Gross Profit
$500,000
EBITDA
-$10.57M
COGS
–
Operating Exp
$12.20M
Operating Income
-$11.70M
EBIT
-$11.70M
Pretax Income
-$10.57M
Net Income
-$10.57M
EPS (Diluted)
-0.05
Price & Volume History
Loading chart…
Recent News
Palisade Bio Presents Rapid Endoscopic Improvement and New Translational Evidence for PALI-2108 in Inflammatory Bowel Disease at UEG Week 2026
GlobeNewswire · Oct 20, 2026 8:05 AM ET
Palisade Bio Presents New Clinical, Pharmacokinetic, Pharmacodynamic and Mechanistic Data Strengthening the Phase 2 Rationale for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at ACG 2026
GlobeNewswire · Oct 12, 2026 8:05 AM ET
Raymond James Initiates Palisade Bio at Outperform With $6 Price Target
MT Newswires · Oct 9, 2026 7:31 AM ET
Palisade Bio to Present Clinical and Translational Data for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at UEG Week 2026
GlobeNewswire · Sep 28, 2026 8:50 AM ET
Palisade Bio Advances PALI-2108 Into Phase II for Ulcerative Colitis and Crohn’s
MarketBeat · Sep 27, 2026 1:01 PM ET
Palisade Bio Gets Clearance for Phase 2 Trial of Ulcerative Colitis Treatment in Canada
MT Newswires · Sep 23, 2026 9:23 AM ET
Palisade Bio Expands Global Phase 2b ASCENTRA-UC Program with Health Canada CTA Clearance
GlobeNewswire · Sep 23, 2026 8:45 AM ET
Palisade Bio Gets FDA Clearance for PALI-2108 in Crohn's Disease
MT Newswires · Sep 22, 2026 10:18 AM ET
Palisade Bio Receives FDA Clearance of IND for PALI-2108 in Crohn’s Disease, Expanding Phase 2 Development Across IBD
GlobeNewswire · Sep 22, 2026 8:35 AM ET
Palisade Bio to Present at Stifel 2026 Virtual Immunology and Inflammation Forum
GlobeNewswire · Sep 21, 2026 9:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See PALI's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.